Cellmid Ltd (cdy) Logo

Cellmid Ltd (CDY)

___:___ · Consumer Defensive
ASX Delayed
Cboe unavailable

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

CDY ASX Chart

Snapshot

Cellmid Limited (CDY) is an Australian life sciences accelerator for indication of multiple diseases. It operates mainly through its wholly owned subsidiaries, Advangen Limited, Kinera and Lyramid Limited, that develop and market innovative novel therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company holds global intellectual properties relating to novel targets midkine and FGF5.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -39.62%
vs ASX 200 (1yr) -50.46%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,758 of 2,384
Sector Rank 66 of 98

Key Fundamentals

Shares Issued
Sector Consumer Defensive
Similar Companies BFC / NUC / MRG
EPS $0.00
DPS $0.00
Book Value Per Share $0.00

Broker Consensus

CDY is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Sydney NSW 2000
Website www.cellmid.com.au
Registry Automic Group
Auditor Pitcher Partners
Date Listed 9 Dec 2005

Upcoming Calendar (Forecasted)

Date Event
17/02/2022 Report (Interim)
18/08/2022 Report (Prelim)
19/09/2022 Report (Annual)

Former Company Names

  • Medical Therapies Limited (MTY) on 19/11/2009.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

CDY directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
22/09/21 Maria Halasz Buy +362,361 $0.055 $20,092 On-market trade
01/04/21 Bruce Gordon Issued 52,000 $0.078 $4,056 Rights issue
01/04/21 Bruce Gordon Issued 104,000 $0.075 $7,800 Rights issue
01/04/21 Maria Halasz Issued 1,259,639 $0.075 $94,472 Rights issue
01/04/21 Maria Halasz Issued 168,000 $0.075 $12,600 Rights issue
01/04/21 Maria Halasz Issued 713,819 $0.078 $55,677 Rights issue
01/04/21 Martin Cross Issued 65,000 $0.078 $5,070 Rights issue
01/04/21 Martin Cross Issued 130,000 $0.075 $9,750 Rights issue
01/04/21 Dennis Eck Issued 2,592,518 $0.078 $202,216 Rights issue
01/04/21 Dennis Eck Issued 5,185,036 $0.075 $388,877 Rights issue
23/12/20 David King Buy +215,000 $0.105 $22,575 Off-market trade
23/12/20 Maria Halasz Buy +210,000 $0.105 $22,050 Off-market trade
23/12/20 Bruce Gordon Buy +100,000 $0.105 $10,500 Off-market trade
15/12/20 Dennis Eck Issued 465,437 $0.107 $50,000 Director remuneration
22/06/20 Maria Halasz Buy +152,789 $0.113 $17,334 On-market trade
18/06/20 Maria Halasz Issued 227,273 $0.220 $50,000 Placement
18/06/20 Dennis Eck Issued 4,318,182 $0.220 $950,000 Placement
20/11/19 Maria Halasz Issued 3,000,000 $0.230 $690,000 Issue of options
20/11/19 Dennis Eck Issued 217,391 $0.230 $50,000 Director remuneration
20/11/19 Dennis Eck Issued 2,500,000 $0.200 $500,000 Placement
20/11/19 Maria Halasz Issued 600,000 $0.200 $120,000 Placement
08/11/19 Bruce Gordon Buy +50,000 $0.200 $10,000 Participation in share purchase plan
08/11/19 Martin Cross Buy +150,000 $0.200 $30,000 Participation in share purchase plan
08/11/19 David King Buy +200,000 $0.200 $40,000 Participation in share purchase plan
08/11/19 David King Buy +100,000 $0.200 $20,000 Participation in share purchase plan
31/05/19 Maria Halasz Buy +12,000 $0.190 $2,280 On-market trade
29/04/19 Maria Halasz Buy +39,000 $0.210 $8,190 On-market trade
15/04/19 Maria Halasz Transfer 400,000 $0.215 $86,000 Off-market transfer
13/11/18 Maria Halasz Issued 500,000 $0.370 $185,000 Issue of securities
13/11/18 Maria Halasz Buy +22,130 $0.350 $7,746 On-market trade
30/10/18 Maria Halasz Issued 500,000 $0.370 $185,000 Issue of securities
20/09/18 Bruce Gordon Buy +8,684 $0.380 $3,300 On-market trade
12/09/18 Maria Halasz Buy +263,157 $0.380 $100,000 Placement
12/09/18 Dennis Eck Buy +2,631,579 $0.380 $1,000,000 Placement
28/03/18 Maria Halasz Buy +100,000 $0.400 $40,000 Off-market trade
12/03/18 Maria Halasz Buy +20,000 $0.470 $9,400 On-market trade
31/01/18 Maria Halasz Buy +70,000 $0.503 $35,197 On-market trade
20/12/17 Maria Halasz Buy +17,500 $0.375 $6,563 On-market trade
14/11/17 Maria Halasz Sell +4,000,000 $0.030 ($120,000) As advised by the company
03/11/17 Maria Halasz Buy +250,000 $0.020 $5,000 On-market trade
31/10/17 Martin Cross Buy +900,000 $0.022 $19,800 On-market trade
31/10/17 Maria Halasz Buy +2,000,000 $0.021 $41,039 On-market trade
30/10/17 Edward Walton Buy +500,000 $0.022 $11,000 On-market trade
30/05/17 Maria Halasz Buy +500,000 $0.026 $13,000 On-market trade
16/05/17 Maria Halasz Buy +57,400 $0.028 $1,607 On-market trade
10/05/17 Maria Halasz Buy +250,000 $0.027 $6,750 On-market trade
28/12/16 Maria Halasz Buy +350,000 $0.026 $9,124 On-market trade
17/11/16 Maria Halasz Buy +500,000 $0.030 $14,836 On-market trade
25/10/16 Maria Halasz Buy +125,625 $0.034 $4,271 On-market trade
17/10/16 Bruce Gordon Exercise 1,000,000 $0.034 $34,000 Exercise of options
17/10/16 Bruce Gordon Buy +1,000,000 $0.034 $34,000 Exercise of options
17/10/16 Bruce Gordon Buy +1,000,000 $0.000 $1 Off-market trade
17/10/16 Edward Walton Buy +250,000 $0.035 $8,750 On-market trade
17/10/16 Edward Walton Buy +250,000 $0.000 $1 Off-market trade
17/10/16 Maria Halasz Buy +1,500,000 $0.034 $51,000 Exercise of options
17/10/16 Maria Halasz Exercise 1,500,000 $0.034 $51,000 Exercise of options
17/10/16 Edward Walton Buy +250,000 $0.034 $8,500 Exercise of options
17/10/16 Edward Walton Exercise 250,000 $0.034 $8,500 Exercise of options
17/10/16 David King Transfer 1,250,000 $0.000 $2 Off-market transfer
16/09/16 Maria Halasz Buy +320,000 $0.029 $9,365 On-market trade
17/06/16 Maria Halasz Buy +652,600 $0.030 $19,350 On-market trade
17/12/15 Maria Halasz Buy +300,000 $0.024 $7,200 On-market trade
19/11/15 Edward Walton Issued 2,000,000 $0.028 $56,000 Issue of options
19/11/15 Bruce Gordon Issued 2,000,000 $0.028 $56,000 Issue of options
19/11/15 David King Issued 4,000,000 $0.028 $112,000 Issue of options
10/08/15 Edward Walton Buy +300,000 $0.035 $10,640 On-market trade
09/03/15 Maria Halasz Buy +242,006 $0.025 $6,050 On-market trade
06/03/15 Maria Halasz Buy +157,994 $0.024 $3,792 On-market trade
17/09/14 Maria Halasz Buy +370,000 $0.027 $9,990 On-market trade
Show All

Director Interests

The current holdings of CDY directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Phillip Christopher 05/11/2021 0 N/A N/A N/A
Maria Halasz 22/09/2021 588,000 4,412,000 3,713,819 N/A
Martin Cross 30/06/2021 N/A 455,000 65,000 N/A
Bruce Gordon 30/06/2021 N/A 364,000 52,000 N/A
Dennis Eck 30/06/2021 18,147,625 N/A 2,592,518 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 16, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Mr Dennis Keith Eck 18,147,625 9.68%
P & M Maguire Super Pty Ltd (P & M Maguire S/F A/C) 8,800,000 4.70%
Moore Family Nominee Pty Ltd (Moore Family Super Fund A/C) 8,425,020 4.50%
Maria Halasz 4,637,639 2.47%
Iq Global Asset Partners Pty Ltd (Iq S/F A/C) 4,462,376 2.38%
Ubs Nominees Pty Ltd 3,663,378 1.95%
Mr Antony Stephen Iles 3,000,000 1.60%
Ms Janet Heather Cameron 2,958,618 1.58%
Ltl Capital Pty Ltd 2,583,333 1.38%
Jasgo Nominees Pty Ltd (Jasgo Family A/C) 2,331,578 1.24%
Seistend (Super) Pty Ltd (Dw King Super Fund A/C) 2,121,000 1.13%
Scintilla Strategic Investments Limited 2,100,000 1.12%
Mr Peter Howells 2,035,000 1.09%
Mr Gregory Glenn Worth (Worth S/F A/C) 2,000,000 1.07%
Citicorp Nominees Pty Limited 1,938,564 1.03%
Evaneu (Nominees) Pty Ltd & Ricneu (Nominees) Pty Ltd (The Evan Ricky Neumann A/C) 1,905,618 1.02%
Mrs Rebecca Shalala 1,859,029 0.99%
Mr Gerald William Simms 1,750,000 0.93%
Mrs Margaret Ann Ryan & Mr Micheal Rodney Ryan 1,550,000 0.83%
Mr Jon David Wood 1,500,000 0.80%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Dennis Keith Eck 16/08/2021 18,147,625 9.68
HGL Limited 02/11/2021 35,157,956 15.97

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
02-11-21 HGL Limited 35,157,956 -- 15.97

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.060 30 June
2020 $0.100 30 June
2019 $0.175 28 June
2018 $0.470 29 June
2017 $0.025 28 June
2016 $0.033 28 June
2015 $0.030 30 June
2014 $0.026 30 June
CDY Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.